Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair loss may target specific pathways and generate new hair follicles.

MCPIP1 in myeloid cells is important for skin cancer development and healthy hair growth.

New treatments targeting the Hedgehog pathway can help treat advanced skin cancer but may have side effects and their effectiveness in early stages is unknown.

Pantethine may boost the immune system's ability to fight sarcoma.

Tissue-derived extracellular vesicles are crucial for cancer diagnosis, prognosis, and treatment.

FOL-005, a hair growth promoter, acts locally on mouse skin where injected and could be a promising hair loss treatment.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

Some cells may slow melanoma growth, a protein could affect skin pigmentation, a gene-silencing method might treat hair defects, skin bacteria changes likely result from eczema, and a defensin protein could help treat multiple sclerosis.

Cellular senescence has both cancer-blocking and cancer-promoting effects, and targeting senescent cells may improve health and lifespan.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Septin4 helps kill colon cancer cells by working with the protein BAX.

Intralesional chemotherapy with 5-fluorouracil and methotrexate may worsen keratoacanthoma-type skin cancer in transplant patients.

The document concludes that transplantology has evolved with improved techniques and materials, making transplants more successful and expanding the types of transplants possible.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Higher levels of nidogen1 and type IV collagen are found in basal cell carcinoma compared to normal skin.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Understanding phenotypic plasticity is crucial for developing effective cancer therapies.

R-spondins and their receptors help increase bone growth and may be used to treat bone loss diseases.

Minoxidil can stop the growth of ovarian cancer cells without harming the heart.

Horse skin diseases are complex to manage and often require a biopsy for accurate diagnosis and treatment.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Activating β-catenin in mammary cells leads to changes that cause early-stage abnormal growths similar to skin structures.

TGF-β is crucial for tissue repair and can cause diseases if not properly regulated.

Mice with human skin protein K8 had more skin problems and cancer.

Distinct β-catenin patterns are linked to cell growth, not cell death, in lung cancer.

Some hair loss disorders are caused by genetic mutations affecting hair growth.

High doses of finasteride cause cell growth and tumors in mice.

HPV16 oncogenes disrupt the normal activity of hair follicle stem cells.